bf/NASDAQ:MYGN_icon.png

COM:MYRIAD

Myriad Genetics

  • Stock

USD

Last Close

15.12

22/11 21:00

Market Cap

2.28B

Beta: -

Volume Today

622.81K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
14.46M
-
24.51M
69.46%
31.70M
29.34%
40.25M
26.97%
38.25M
4.97%
32.85M
14.12%
30.25M
7.91%
29.25M
3.31%
22.20M
24.10%
17.70M
20.27%
21.05M
18.93%
average payables
20.61M
-
22.09M
7.20%
21.10M
4.48%
21.55M
2.13%
24M
11.37%
29.65M
23.54%
27.50M
7.25%
26.90M
2.18%
25.65M
4.65%
29.20M
13.84%
27.30M
6.51%
average receivables
98.19M
-
93.19M
5.10%
91.35M
1.97%
103.15M
12.92%
106.70M
3.44%
120.35M
12.79%
104.80M
12.92%
114.05M
8.83%
81.15M
28.85%
96.45M
18.85%
107.95M
11.92%
book value per share
9.49
-
9.29
2.19%
10.69
15.09%
11.39
6.61%
13.90
22.03%
14.81
6.56%
12.36
16.58%
11.79
4.56%
12.41
5.20%
10.99
11.43%
9.46
13.93%
capex per share
-0.19
-
-0.34
77.87%
-0.07
78.69%
-0.09
25.04%
-0.12
35.52%
-0.12
3.33%
-0.14
17.33%
-0.18
28.72%
-0.23
30.59%
-0.56
143.55%
0.89
257.51%
capex to depreciation
-1.03
-
-0.96
7.43%
-0.19
80.41%
-0.13
32.56%
-0.15
22.26%
-0.12
23.71%
-0.14
20.25%
-0.18
30.50%
-0.29
55.04%
-0.86
199.90%
1.18
237.76%
capex to operating cash flow
-0.08
-
-0.17
126.73%
-0.03
82.33%
-0.06
91.04%
-0.07
26.18%
-0.10
41.77%
-0.17
63.55%
0.49
392.02%
-0.99
301.55%
0.43
143.09%
-0.66
255.10%
capex to revenue
-0.02
-
-0.03
80.24%
-0.01
79.93%
-0.01
19.22%
-0.01
37.49%
-0.01
7.06%
-0.02
58.07%
-0.02
48.37%
-0.03
9.98%
-0.07
156.19%
0.10
245.74%
cash per share
2.46
-
2.03
17.52%
2.27
11.85%
2.21
2.86%
2.60
17.94%
1.86
28.43%
2.93
57.38%
2.02
31.18%
4.36
115.94%
1.43
67.28%
1.70
19.37%
days of inventory on hand
79.95
-
62.15
22.26%
88.87
42.99%
89.97
1.24%
70.65
21.47%
57.02
19.29%
57.07
0.10%
55.51
2.74%
28.26
49.09%
36.32
28.51%
34.00
6.40%
days payables outstanding
77.14
-
52.25
32.26%
48.96
6.29%
46.90
4.20%
53.56
14.18%
60.47
12.91%
42.56
29.62%
41.99
1.34%
54.68
30.21%
52.04
4.82%
39.87
23.39%
days sales outstanding
46.28
-
44.27
4.35%
46.00
3.91%
52.66
14.48%
48.24
8.41%
59.44
23.23%
40.58
31.73%
58.65
44.52%
48.25
17.72%
54.66
13.28%
55.39
1.33%
debt to assets
0.13
-
0.07
50.87%
0.20
202.47%
0.21
4.99%
0.16
24.51%
0.07
55.89%
0.12
73.09%
0.03
72.24%
debt to equity
0.21
-
0.08
62.00%
0.29
256.73%
0.32
11.91%
0.26
20.53%
0.10
62.62%
0.16
71.64%
0.05
69.97%
dividend yield
0.23
-
0.17
-
earnings yield
0.06
-
0.03
44.65%
0.06
76.77%
0.01
78.88%
0.05
308.93%
0.00
95.49%
-0.24
10,500.29%
-0.15
36.03%
-0.01
91.66%
-0.10
657.97%
-0.17
73.49%
enterprise value
2.88B
-
2.36B
18.15%
2.07B
12.12%
1.76B
15.04%
2.49B
41.46%
2.16B
13.29%
973.66M
54.94%
1.36B
39.66%
1.99B
46.10%
1.26B
36.70%
1.60B
27.61%
enterprise value over ebitda
10.50
-
14.82
41.10%
10.72
27.70%
18.27
70.53%
21.99
20.36%
25.10
14.11%
-22.33
188.98%
-11.02
50.66%
140.90
1,378.66%
-18.55
113.16%
-8.62
53.51%
ev to operating cash flow
15.15
-
16.79
10.81%
12.47
25.75%
16.59
33.03%
21.50
29.62%
25.82
20.07%
16.04
37.87%
-50.55
415.14%
109.16
315.94%
-11.83
110.84%
-14.47
22.31%
ev to sales
3.70
-
3.26
11.91%
2.75
15.70%
2.28
16.98%
3.23
41.24%
2.54
21.28%
1.52
39.95%
2.44
60.12%
2.88
17.84%
1.85
35.56%
2.13
14.93%
free cash flow per share
2.32
-
1.64
29.61%
2.30
40.91%
1.47
36.40%
1.55
5.69%
1.02
34.04%
0.68
33.48%
-0.54
178.98%
0.00
100.48%
-1.88
73,454.84%
-2.22
18.28%
free cash flow yield
0.06
-
0.05
19.40%
0.08
56.52%
0.06
24.68%
0.04
26.92%
0.04
10.33%
0.06
61.25%
-0.03
145.30%
0.00
100.34%
-0.13
139,630.91%
-0.12
10.34%
graham net net
2.21
-
1.67
24.58%
1.67
0.12%
-2.80
267.60%
0.94
133.50%
-2.96
414.98%
-2.70
8.57%
-4.10
51.79%
0.81
119.70%
-1.39
271.59%
-1.52
9.47%
graham number
22.30
-
15.33
31.24%
20.75
35.33%
9.05
56.40%
24.30
168.64%
4.57
81.20%
27.32
498.23%
28.19
3.17%
9.87
65.00%
18.54
87.87%
26.01
40.34%
income quality
1.08
-
1.75
62.30%
1.33
24.24%
4.87
267.05%
0.88
81.84%
18.20
1,956.63%
-0.30
101.67%
0.12
139.52%
-0.67
656.44%
0.95
241.84%
0.42
55.62%
intangibles to total assets
0.45
-
0.48
6.17%
0.48
0.51%
0.66
37.38%
0.66
0.09%
0.71
6.99%
0.66
5.81%
0.64
3.64%
0.49
23.89%
0.56
14.15%
0.56
0.09%
interest coverage
8.23
-
37.09
350.53%
0.63
98.29%
-21.45
3,487.43%
-7.38
-
-38.66
423.88%
-88.76
129.61%
interest debt per share
2.50
-
1.16
53.42%
4.41
279.09%
4.11
6.81%
3.01
26.83%
1.27
57.87%
1.84
45.01%
0.50
72.81%
inventory turnover
4.57
-
5.87
28.63%
4.11
30.06%
4.06
1.22%
5.17
27.34%
6.40
23.91%
6.40
0.10%
6.58
2.82%
12.92
96.41%
10.05
22.19%
10.74
6.83%
invested capital
0.21
-
0.08
62.00%
0.29
256.73%
0.32
11.91%
0.26
20.53%
0.10
62.62%
0.16
71.64%
975.20M
595,746,317,141.38%
market cap
2.95B
-
2.42B
17.77%
2.14B
11.61%
1.76B
17.61%
2.59B
46.95%
2.02B
22.09%
842.56M
58.30%
1.48B
75.27%
2.15B
45.78%
1.17B
45.68%
1.58B
35.51%
net current asset value
295.29M
-
179.50M
39.21%
182.10M
1.45%
-129.50M
171.11%
117.20M
190.50%
-125.20M
206.83%
-154.70M
23.56%
-148.40M
4.07%
131.90M
188.88%
-38.30M
129.04%
-49.70M
29.77%
net debt to ebitda
-0.24
-
-0.40
70.47%
-0.35
12.08%
-0.03
90.33%
-0.90
2,519.55%
1.63
281.71%
-3.01
284.53%
0.95
131.53%
-11.78
1,342.45%
-1.30
88.97%
-0.11
91.73%
net income per share
2.33
-
1.12
51.66%
1.79
59.14%
0.32
82.17%
1.89
491.39%
0.06
96.68%
-2.69
4,390.26%
-2.99
11.53%
-0.35
88.36%
-1.39
298.48%
-3.18
128.84%
operating cash flow per share
2.51
-
1.97
21.55%
2.38
20.56%
1.55
34.55%
1.67
7.40%
1.14
31.81%
0.82
28.26%
-0.36
144.08%
0.23
164.79%
-1.32
665.23%
-1.34
1.56%
payables turnover
4.73
-
6.99
47.63%
7.45
6.72%
7.78
4.38%
6.82
12.42%
6.04
11.44%
8.58
42.08%
8.69
1.36%
6.68
23.20%
7.01
5.07%
9.16
30.53%
receivables turnover
7.89
-
8.25
4.55%
7.93
3.76%
6.93
12.65%
7.57
9.18%
6.14
18.85%
8.99
46.47%
6.22
30.81%
7.56
21.54%
6.68
11.73%
6.59
1.31%
research and ddevelopement to revenue
0.09
-
0.10
20.42%
0.09
10.30%
0.10
2.98%
0.09
4.99%
0.10
10.14%
0.12
19.78%
0.15
20.14%
0.12
18.35%
0.13
6.15%
0.12
6.45%
return on tangible assets
0.39
-
0.20
48.41%
0.27
35.31%
0.05
80.89%
0.33
525.54%
0.01
96.95%
-0.42
4,336.74%
-0.44
3.55%
-0.04
90.83%
-0.21
424.11%
-0.52
145.52%
revenue per share
10.28
-
10.14
1.31%
10.77
6.18%
11.29
4.88%
11.13
1.43%
11.58
4.02%
8.59
25.78%
7.46
13.24%
8.85
18.74%
8.42
4.94%
9.10
8.08%
roe
0.25
-
0.12
50.58%
0.17
38.27%
0.03
83.27%
0.14
384.64%
0.00
96.89%
-0.22
5,243.23%
-0.25
16.87%
-0.03
88.93%
-0.13
349.88%
-0.34
165.89%
roic
0.24
-
0.12
50.22%
0.17
37.27%
0.03
84.05%
0.13
382.96%
0.01
93.31%
-0.16
1,993.47%
-0.21
32.21%
-0.02
90.56%
-0.08
316.30%
-0.31
275.36%
sales general and administrative to revenue
0.87
-
0.76
12.64%
0.76
0.25%
shareholders equity per share
9.49
-
9.29
2.19%
10.69
15.09%
11.39
6.61%
13.90
22.03%
14.81
6.56%
12.36
16.58%
11.79
4.56%
12.41
5.20%
10.99
11.43%
9.46
13.93%
stock based compensation to revenue
0.03
-
0.06
81.70%
0.04
33.67%
0.04
7.54%
0.04
9.51%
0.04
12.21%
0.04
0.26%
0.04
10.56%
0.05
20.48%
0.06
6.85%
0.05
3.78%
tangible asset value
344.50M
-
292.30M
15.15%
325.30M
11.29%
-29.90M
109.19%
191.10M
739.13%
-13M
106.80%
-14.70M
13.08%
-27M
83.67%
324.50M
1,301.85%
219.30M
32.42%
146.30M
33.29%
tangible book value per share
4.55
-
4.10
9.88%
4.65
13.36%
-0.44
109.42%
2.75
729.00%
-0.18
106.42%
-0.20
11.86%
-0.36
82.69%
4.16
1,250.98%
2.72
34.60%
1.77
35.06%
working capital
319.52M
-
214.90M
32.74%
242.20M
12.70%
99.60M
58.88%
224.20M
125.10%
230.80M
2.94%
184.70M
19.97%
243.50M
31.84%
280.50M
15.20%
137.40M
51.02%
157.70M
14.77%

All numbers in USD (except ratios and percentages)